Demographic and pattern of childhood acute leukemia in Duhok, Kurdistan region of Iraq, 2009-2018

Adnan Anwer Sedeeq  AL-doski

doi:10.56056/amj.2020.114

Authors

Adnan Anwer Sedeeq AL-doski M.B.Ch.B., F.I.B.M.S, Assistant professor, Department of Pathology, College of Medicine, University of Duhok, Duhok, Iraq.

DOI:

https://doi.org/10.56056/amj.2020.114

Keywords:

Acute leukemia, Childhood, Duhok, Incidence rate

Abstract

Background and objectives: Leukemia is a common childhood cancer, constituting more than 25% in many pop- ulations. The most frequent type of childhood leukemia is acute lymphoblastic leukemia. The aim of this study is to describe the annual incidence, rate and demographics of acute childhood leukemia and their patterns in Duhok, Kurdistan - Iraq, in the period from 2009 to 2018.

Methods:It is a retrospective study that was conducted at Heevi Pediatric Teaching Hospital in Duhok. A total of 198 patients, who were diagnosed as new cases of acute leukemia and were less than 15 years of age in the past ten years (from 2009 to 2018), were included in this study. Demographic data and the presenting hematological values of acute leukemia, based on cytomorphologic characteristics of bone marrow leukemic blast cells, were studies.

Results: Childhood acute leukemia represented about 40 % of the total percentage of cancers among children in Duhok. It was more predominant in boys (53.5%) than in girls (46.5%). The cases peaked at 2-10 years cohort (69.2%). The number of cases ranged from 17 cases in 2009 to 15 cases in 2018 and reached a peak of 31 cases in 2016. The most prevalent type of leukemia was Acute Lymphoblastic Leukemia (ALL) (161 cases, 81.6%), followed by Acute Myeloid Leukemia (37 cases, 18.4%). The overall annual incidence rate was 2.0 cases /100,000 per year. The yearly incidence rates of leukemia were 1.3 – 2.4 cases /100,000. The highest incidence rate was in Duhok center (2.4 cases /100,000) and Zakho (2.3 cases /100,000); however, the least incidence rate was in Amedi (1.3 cases /100,000). The incidence of ALL appears to be nearly fourfold higher than the incidence of Acute Myeloid Leukemia in different areas of Duhok.

Conclusions:It was found that childhood acute leukemia had lower prevalence in Duhok, and the clinical hematological features were similar to that of other studies.

Downloads

Download data is not yet available.

References

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 2017; 7(6), e577. http://doi.org/10.1038/ bcj.2017.53.

Forman D, Bray F, Brewster DH et al. Cancer Incidence in Five Continents Vol. 10. International Agency for Research on Cancer Lyon, France 2014.

Foucher ES, Colombet M, Reis LA et al. International incidence of child- hood cancer, 2001–2010: a population-based registry study. Lancet Oncol.2017;18(6):719–31. doi: 10.1016/S1470-2045(17)30186-9.

Spector LG, Pankratz N, Marcotte EL. Nongenetic Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin North Am. 2015; 62(1): 11–25.

Stiller CA, ed. Childhood cancer in Britain: incidence, survival, mortality. Oxford, Oxford University Press, 2007.

Christensen K, Savage S, Huntington N, et al. Epidemiology and genetics of childhood cancer. Journal of Empirical Research on Human Research Ethics 2017; 12 (2): 97 –106. doi: 10.1177/1556264617697839.

Belson M, Kingsley B, Holme A. Risk factors for acute leukemia in children: a review. Environmental Health Perspectives, 2007, 115:138-45.

O’Connor SM, Boneva RS. Infectious etiologies of childhood leukemia: plausibility and challenges to proof, Environmental Health Perspectives, 2007, 115:146–50.

Zachek CM, Miller MD, Christopher H. et al. Children’s Cancer and Environmental Exposures: Professional Attitudes and Practices. Journal of Pediatric Hematology/Oncology: 2015; 37(7), 491–7.

Urayama KY, Wiencke JK, Buffler PA et al. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiology Biomarkers and Prevention, 2007, 16:1172–77.

Abbasi S, Maleha F, Shoba K. Acute Lymphoblastic Leukemia Experiences: epidemiology and Outcome of Two Different Regimens. Mediterr J Haematol Infect Dis 2013; 5(1): e2013024.

Committee on Medical Aspects of Radiation in the Environment (COMARE). Eleventh report.The distribution of childhood leukaemia and other childhood cancers in Great Britain.London,Health Protection Agency, 2006 http://www.comare. org.uk/press_releases/documents/COMARE11thRe port.pdf.

Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992- 2004). Cancer. 2008; 112:416-32.

Swami N, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990- 2001: Incidence and survival. Int J Cancer 2008; 122:2607/11.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: Globocan; 2018. https://doi.org/10.3322/ caac.21492.

Zhang L, Samad A, Pombo-de-Oliveira MS et al. Characteristics of Childhood Acute Promyelocytic Leukemia. Blood Rev. 2015; 29(2): 101–25.

Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, oplack DG, Eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins. 15th ed. 2006. Pp. 538–90.

Wagner A. Sarcoma, An Issue of Hematology/Oncology Clinics of North Ameri- ca. Int J Cancer 2012; 13: E508–17.

Al Nasser A, El Solh H, De Vol E. Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: A single-institution experience. Ann Saudi Med 2008; 28(4): 251-9.

Aziz SA, Sharma SK, Sabah I, Jan MA. Prognostic significance of cell surface phenotype in acute lymphoblastic leukemia. South Asian J Cancer 2015; 4(2): 91- 4.

Wigle D, Turner M, Krewski D. A Systematic Review and Meta-analysis of Childhood Leukemia and Parental Occupational Pesticide Exposure. Environ Health Perspect. 2009; 117(10): 1505–13.

Arora B, Kanwar V. Childhood cancers in India: Burden, barriers, and break- throughs. Int J Cancer. 2009;( 46)4: 257-9.

Moricke A, Zimmerman M, ReiterA. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: Data from the trials ALL-BFM 86,90, and 95. Klin Pediatr. 2010; 217: 310-20.

Jalal SD, Al-Allawi NA, Al Doski AA. Immunophynotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients. Int J Lab Hematol 2017; 39(6):625-32.

Environment in Iraq. UNEP Progress Report, UN, Geneva, 2003. From: http:// postconflict.unep.ch/ publications/Iraq_PR.pdf Accessed: 2010.

Rajalekshmy KR, Abitha AR, Anuratha N, Sagar TG. Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, and south India during the period 1989-2009: Indian J. Cancer. 2011; 48: 310-15.

Koushik A, King W, McLaughlin W. An Ecologic Study of Childhood Leukemia and Population Mixing in Ontario, Canada. Cancer Causes & Control, 2011(12) 6: 483-90.

Adam M, Kuehni C, Spoerri A. Socioeconomic Status and Childhood Leukemia Incidence in Switzerland. Front Oncol. 2015; 5: 139.

Higgins CD, dos Santos-Silva I, Stiller CA, Swerdlow AJ. Risk Factors for Acute Leukemia in Children: A Review, Season of birth and diagnosis of children with leukemia. An analysis of over 15,000 UK cases. Br J Cancer. 2007. 115(1):138-45.

Silverman L. Acute lymphoblastic leukemia. Oncology of infancy and child- hood. 2009; 10:279-317.

Abdurrahman K, AI Allawi N, Muhsen A. Pattern of Acute Lymphoblastic Leukemia Among Kurdish Children in Duhok City, Northern Iraq: Qatar med. J. 2011;20(2), 17-20.

Moricke A, ReiterA, Zimmermann M. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008; 111:4477-89.

Tong H, Wang Q, Lu C, Liu Z, Hu Y. Immunophenotypic, cytogenetics and clinical features of 207 acute lymphoblastic leukemia in China. J Pediatr Hematol Oncol 2015; 33:437-41.

Kanerva J. The French-American-British (FAB) classification of leukemia. Prognostic factors in childhood acute lymphoblastic leukemia. 2002; 57:1046-51.